Life Technologies Corporation is a biotechnology company based in the United States. It was founded by a group of investors led by John C. Whitfield, III. John C. Whitfield, III is a former vice president of Sederma, a biotechnology company. In the late 1980s, he joined the board of Sederma, which was one of the few companies to gain publicly listed stock on the New York Stock Exchange.
Life Technologies Corporation is a major supplier of life sciences reagents and equipment. It is involved in the research, development, manufacture, and distribution of pharmaceuticals and generic drug products used in the field of life sciences. It also manufactures and distributes equipment and reagents used in the field of agriculture, animal nutrition, and cell culture. Most of its products are under the name of “Cell Culture Techniques”.
Life Technologies has recently entered into a partnership with Astraware to form a new enterprise called Astraware Inc. This company will be responsible for developing and commercializing Life Technologies and Cell Biology Instruments. The partnership is a strategic alliance that sees the two companies working together to accelerate scientific exploration in life sciences. This would enable faster and more accurate measurements of specific proteins and cells used in cell biology and clinical laboratory research.
Ciba Vision is another Life Technologies product. It is a high-performance confocal microscope. Ciba Vision uses patented technology to enable easy and accurate visual inspection of tissue samples and cell cultures. This specialized microscope is fully equipped to conduct high-resolution and high magnification studies of various biological samples. The Ciba Vision line of products incorporates the latest technology and highly technical methodologies used in the Life Technologies’ line of specialty diagnostics. This means that Ciba Vision’s customers can expect precision performance in terms of efficiency, reproducibility, and accuracy in terms of signal resolution.
Ciba Vision also works closely with several other well-known cell culture and life technologies companies including Kary Mullis, Garaventa, and Syngenta. The Life Technologies forensics team at Cybex is responsible for developing the Cellulean system for the detection and rapid identification of pathogenic agents. The system uses a novel, automated workflow that automates the acquisition, quality control, validation, and packaging of cell culture and animal blood samples. It can be fully automated when the appropriate software modules are installed on the Cybex systems.
There are a number of factors that affect operating results. These include but are not limited to pricing, service, support, supportability, training, development, marketing, demand, and competition. The company has developed an operating strategy to strengthen its competitive position and strengthen its position in the industry. A key aim is to improve our customer satisfaction levels and to improve productivity and reduce cost. These are some of the important factors that influence the operating results of Life Technologies.